Literature DB >> 12943662

Identification and characterization of Xenopus NDRG1.

Jun-ichi Kyuno1, Akimasa Fukui, Tatsuo Michiue, Makoto Asashima.   

Abstract

NDRG1 is a member of the N-myc downstream-regulated gene (NDRG) family and is involved in cellular differentiation, activation of p53, cell cycle arrest, metastasis, and hypoxia. Expression of NDRG1 is repressed by the proto-oncogene, N-myc during mouse development, although the exact functional role of NDRG1 in development remains unknown. Here, we report the characterization of Xenopus laevis NDRG1 (xNDRG1) during X. laevis development. Expression of xNDRG1 transcript was first detected at stage 15, and was localized to the presumptive pronephric anlagen at stage 26 and to pronephros, eye, branchial arches, and tail-bud at stage 32. Overexpression of xNDRG1 results in a reduced pronephros and disorganized somites. Depletion of xNDRG1, using morpholinos, causes failure of pronephros development. These results suggest that xNDRG1 is required for pronephros development in X. laevis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943662     DOI: 10.1016/s0006-291x(03)01522-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Interaction of Sox1, Sox2, Sox3 and Oct4 during primary neurogenesis.

Authors:  Tenley C Archer; Jing Jin; Elena S Casey
Journal:  Dev Biol       Date:  2010-12-11       Impact factor: 3.582

2.  NDRG4 is required for cell cycle progression and survival in glioblastoma cells.

Authors:  Stephen H Schilling; Anita B Hjelmeland; Daniel R Radiloff; Irwin M Liu; Timothy P Wakeman; Jeffrey R Fielhauer; Erika H Foster; Justin D Lathia; Jeremy N Rich; Xiao-Fan Wang; Michael B Datto
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

3.  A splice altering variant in NDRG1 gene causes Charcot-Marie-Tooth disease, type 4D.

Authors:  Pooja Pravinbabu; Vikram V Holla; Prashant Phulpagar; Nitish Kamble; Manjunath Netravathi; Ravi Yadav; Pramod Kumar Pal; Babylakshmi Muthusamy
Journal:  Neurol Sci       Date:  2022-02-11       Impact factor: 3.307

4.  Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish.

Authors:  Xianghu Qu; Haibo Jia; Deborah M Garrity; Kevin Tompkins; Lorene Batts; Bruce Appel; Tao P Zhong; H Scott Baldwin
Journal:  Dev Biol       Date:  2008-03-06       Impact factor: 3.582

5.  Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm.

Authors:  Zhen Wang; Fang Wang; Wei-Qi Wang; Qian Gao; Wan-Li Wei; Yun Yang; Guo-Ying Wang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

6.  Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients.

Authors:  Boqian Sun; Dake Chu; Wei Li; Xiaodan Chu; Yunming Li; Dun Wei; Haiping Li
Journal:  J Neurooncol       Date:  2009-04-01       Impact factor: 4.130

7.  Retinoic acid-activated Ndrg1a represses Wnt/β-catenin signaling to allow Xenopus pancreas, oesophagus, stomach, and duodenum specification.

Authors:  Tiejun Zhang; Xiaogang Guo; Yonglong Chen
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients.

Authors:  Dake Chu; Zixi Zhang; Yi Zhou; Yunming Li; Shaojun Zhu; Jian Zhang; Qingchuan Zhao; Gang Ji; Weizhong Wang; Jianyong Zheng
Journal:  Oncotarget       Date:  2015-04-10

Review 9.  In Vitro organogenesis using amphibian pluripotent cells.

Authors:  Koji Okabayashi; Makoto Asashima
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2006-11-18       Impact factor: 3.493

10.  The N-Myc down regulated Gene1 (NDRG1) Is a Rab4a effector involved in vesicular recycling of E-cadherin.

Authors:  Sushant K Kachhap; Dennis Faith; David Z Qian; Shabana Shabbeer; Nathan L Galloway; Roberto Pili; Samuel R Denmeade; Angelo M DeMarzo; Michael A Carducci
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.